Literature DB >> 16788123

Statins and the risk of cancer.

Robin E Duncan, Ahmed El-Sohemy, Michael C Archer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16788123     DOI： 10.1001/jama.295.23.2720-a

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  9 in total

1.  An analysis of the association between statin use and risk of endometrial and ovarian cancers in the Women's Health Initiative.

Authors:  Pinkal Desai; Robert Wallace; Matthew L Anderson; Barbara V Howard; Roberta M Ray; Chunyuan Wu; Monika Safford; Lisa W Martin; Thomas Rohan; JoAnn E Manson; Michael S Simon
Journal:  Gynecol Oncol       Date:  2018-02-13       Impact factor: 5.482

2.  Statin use and risk of skin cancer.

Authors:  Brian M Lin; Wen-Qing Li; Eunyoung Cho; Gary C Curhan; Abrar A Qureshi
Journal:  J Am Acad Dermatol       Date:  2017-12-05       Impact factor: 11.527

3.  Prospective analysis of association between use of statins or other lipid-lowering agents and colorectal cancer risk.

Authors:  Michael S Simon; Carol A Rosenberg; Rebecca J Rodabough; Phillip Greenland; Ira Ockene; Hemant K Roy; Dorothy S Lane; Jane A Cauley; Janardan Khandekar
Journal:  Ann Epidemiol       Date:  2011-11-04       Impact factor: 3.797

4.  Prospective analysis of association between use of statins and melanoma risk in the Women's Health Initiative.

Authors:  Deepa Jagtap; Carol A Rosenberg; Lisa W Martin; Mary Pettinger; Janardan Khandekar; Dorothy Lane; Ira Ockene; Michael S Simon
Journal:  Cancer       Date:  2012-03-20       Impact factor: 6.860

5.  The effect of genetic variants on the relationship between statins and breast cancer in postmenopausal women in the Women's Health Initiative observational study.

Authors:  Cathryn H Bock; Allison M Jay; Gregory Dyson; Jennifer L Beebe-Dimmer; Michele L Cote; Lifang Hou; Barbara V Howard; Pinkal Desai; Kristen Purrington; Ross Prentice; Michael S Simon
Journal:  Breast Cancer Res Treat       Date:  2017-10-24       Impact factor: 4.872

6.  Ezetimibe is an inhibitor of tumor angiogenesis.

Authors:  Keith R Solomon; Kristine Pelton; Kelly Boucher; Jinsoo Joo; Christopher Tully; David Zurakowski; Carl P Schaffner; Jayoung Kim; Michael R Freeman
Journal:  Am J Pathol       Date:  2009-01-29       Impact factor: 4.307

7.  An actionable sterol-regulated feedback loop modulates statin sensitivity in prostate cancer.

Authors:  Joseph Longo; Peter J Mullen; Rosemary Yu; Jenna E van Leeuwen; Mehdi Masoomian; Dixon T S Woon; Yuzhuo Wang; Eric X Chen; Robert J Hamilton; Joan M Sweet; Theodorus H van der Kwast; Neil E Fleshner; Linda Z Penn
Journal:  Mol Metab       Date:  2019-04-10       Impact factor: 7.422

8.  Lipid metabolism and cancer.

Authors:  Xueli Bian; Rui Liu; Ying Meng; Dongming Xing; Daqian Xu; Zhimin Lu
Journal:  J Exp Med       Date:  2021-01-04       Impact factor: 14.307

Review 9.  Cholesterol metabolism and tumor.

Authors:  Ying Meng; Qifei Wang; Zhimin Lyu
Journal:  Zhejiang Da Xue Xue Bao Yi Xue Ban       Date:  2021-02-25
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.